Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Chronic Non-Cancer Pain
NCT04044729Phase 1Completed
- Sponsor
- University of Utah
- Start
- Mar 2020
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in chronic pain comparing Cannabidiol with Placebo (2 arms). Primary endpoint: Neurochemical Brain Changes at 5 days. Started Mar 2020; status: completed.
02
Drugs
cannabidiol
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT04044729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04044729.